Inozyme Pharma, Inc. - stock earnings
INZY Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | -21.5 million USD | ? USD |
| 2023Q3 | -16.6 million USD | ? USD |
| 2023Q2 | -15.6 million USD | ? USD |
| 2023Q1 | -16.2 million USD | ? USD |
| 2022Q4 | -17.6 million USD | ? USD |
| 2022Q3 | -15.8 million USD | ? USD |
| 2022Q2 | -14.9 million USD | ? USD |
| 2022Q1 | -16.9 million USD | ? USD |
| 2021Q4 | -18.8 million USD | ? USD |
| 2021Q3 | -14.3 million USD | ? USD |
| 2021Q2 | -12.5 million USD | ? USD |
| 2021Q1 | -11.1 million USD | ? USD |
| 2020Q4 | -11.1 million USD | ? USD |
| 2020Q3 | -28.1 million USD | ? USD |
| 2020Q2 | -9.5 million USD | ? USD |
| 2020Q1 | -7.7 million USD | ? USD |
| 2019Q4 | -6.5 million USD | ? USD |
| 2019Q3 | -4.0 million USD | ? USD |
| 2019Q2 | -4.2 million USD | ? USD |
| 2019Q1 | -5.0 million USD | ? USD |
INZY Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -71.2 million USD | ? USD |
| 2022 | -65.4 million USD | ? USD |
| 2021 | -56.4 million USD | ? USD |
| 2020 | -55.8 million USD | ? USD |
| 2019 | -18.6 million USD | ? USD |
| 2018 | -7.0 million USD | ? USD |
INZY
Price: $4.74
52 week price:
Earnings Per Share: -1.37 USD
P/E Ratio: -3.69
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 94105
Market Capitalization: 396.0 million